Why a Food Export Can Be Rejected After It Has Been Shipped

A food order can be paid for, packed correctly for the buyer and shipped on time, yet still fail at the destination. Commercial acceptance and legal admissibility are different decisions. A customer may like the product while an authority needs evidence about its manufacturer, ingredients, process, label or condition. The expensive mistake is discovering that distinction only after transport, inventory and deadlines are already committed.

For the United States, FDA review is part of a wider import process involving Customs and Border Protection. An entry declaration does not itself establish that FDA-regulated food may be distributed. The agency assesses the information and, where appropriate, the goods against applicable requirements. Other destinations have different systems; a successful American shipment is not blanket approval for Europe, Japan or another market. Source 1

The order needs two specifications

The buyer’s specification might cover flavour, weight, packaging, price and delivery date. The destination specification asks additional questions: is the ingredient permitted for this use, does this product require a particular registration or process filing, and is the label suitable for the market? The two documents should agree before production. A buyer’s informal reassurance cannot supply a record that the manufacturer was supposed to create during processing.

Build one shipment file around the actual product, factory and lot. Avoid a folder of certificates that look impressive but refer to a different facility or product. A test result for last year’s formulation may contribute background information; it cannot automatically establish the condition of this batch. Likewise, a food-safety certificate for a processor does not correct an inaccurate ingredient declaration on the final retail package.

A hold is not yet a refusal

FDA detention creates an opportunity to respond to an apparent violation. Detention without physical examination can arise under an import alert: the agency need not open every shipment before acting. A notice, a laboratory request and a final refusal are therefore different events. The response should address the stated problem rather than send unrelated paperwork in the hope that volume will substitute for relevance. Source 2

What inspection can reveal

An examination can concern conditions that paperwork does not adequately describe: damage, temperature, contamination or the physical identity of the shipment. FDA may collect representative samples and communicates action through notices. Its guidance does not promise one fixed interval for every admissibility decision. A schedule that budgets no time for a hold is consequently a commercial gamble, even when the manufacturer expects compliance. Source 3

The exporter should know who has authority to access the goods, preserve temperature records and arrange a response. A freight agent may handle movement without having the manufacturing knowledge needed to answer a process question. A laboratory may analyse a sample without knowing whether that sample properly represents the detained lot. Clear responsibilities prevent the same unanswered question from circulating among several companies.

Some failures begin inside the factory

For applicable low-acid canned and acidified foods, process filing is a separate requirement from a routine end-product test. FDA’s Import Alert 99-37 addresses missing scheduled-process filings, including product and container particulars. This is not an instruction to classify every Filipino bottled sauce in one category: the manufacturer must establish the correct classification and requirements for its own product. Source 5

That distinction explains why testing more finished jars may be the wrong first response. Where the deficiency concerns the validated process or its filing, the necessary evidence lies upstream. The same logic applies to other mismatches: testing cannot repair a label that declares the wrong ingredient, and a corrected invoice cannot reverse a temperature excursion. Diagnosis determines whether a proposed remedy is relevant.

Before a first commercial shipment, hold a document rehearsal. Ask someone who did not prepare the file to trace one retail unit back to its production lot, ingredient records, packing run and shipment. Can the business identify which other units share the potentially affected input? Can it separate those goods from unrelated stock? The exercise is useful even when no border officer ever requests the complete chain.

Price the interruption, not just the inspection

A hold can create storage costs, demurrage, testing expenses, document work and a delayed customer payment. Perishable inventory can also lose saleable life while everyone waits. Those are distinct costs. Charging them all to “shipping” hides the underlying problem and makes prevention look more expensive than it really is.

Consider a hypothetical order with expected proceeds of ₱500,000 and production, packing and ordinary logistics costs of ₱400,000. Its contribution before general overhead is ₱100,000. A hold adding ₱35,000 reduces that contribution to ₱65,000 if the sale eventually proceeds unchanged. It does not follow that a refusal loses only ₱35,000: the business must then assess unrecovered product costs, any customer obligation, disposition expenses and recoveries. These assumed figures illustrate the accounting distinction; they are not typical inspection charges.

A prevention expense can be evaluated against a particular failure rather than a vague fear of exports. For example, improved lot records may reduce the quantity held unnecessarily during an investigation. Better artwork control may avoid a label mismatch. Neither guarantees release, but both address an identifiable exposure. Keep the expected benefit separate from the cost of complying with a mandatory requirement, which is not optional merely because an estimated failure probability seems low.

When the decision is final

FDA describes refusal as its final decision that an unresolved shipment may not enter US commerce. Refused goods generally must be exported or destroyed under the relevant supervision within 90 days of the refusal notice. The agency distinguishes its role from CBP’s handling of that period. The exact notice must guide the importer’s actions; an exporter should not improvise a local resale or disposal route. Source 4

Contracts should therefore address who makes disposition decisions, who pays for a failed shipment and how recoveries are credited. Those terms deserve attention before a dispute, while both parties still want the transaction to succeed. A clear contract cannot override an authority’s decision, but it can prevent an additional commercial argument from consuming the time available to comply.

The best export file is not the thickest one. It is the file whose product identity, process evidence, label, lot records and transport instructions describe the same shipment. Border risk becomes more manageable when that consistency is established before dispatch, with a named person responsible for answering each kind of question. Product-specific legal and technical advice remains necessary where classification or obligations are uncertain.